CYP2C19 and coronary artery disorder: A collaborative meta-analysis conducted by Mega et al. [6] including patients with acute coronary heart disease (CHD) and treated with clopidogrel showed that carriage of even one reduced-function CYP2C19 allele was associated with a significantly increased risk of adverse cardiovascular events.